These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30669674)

  • 1. Cord-Blood Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes.
    Lamichhane S; Ahonen L; Dyrlund TS; Dickens AM; Siljander H; Hyöty H; Ilonen J; Toppari J; Veijola R; Hyötyläinen T; Knip M; Oresic M
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30669674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of Plasma Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes - Type 1 Diabetes Prediction and Prevention Study (DIPP).
    Lamichhane S; Ahonen L; Dyrlund TS; Kemppainen E; Siljander H; Hyöty H; Ilonen J; Toppari J; Veijola R; Hyötyläinen T; Knip M; Oresic M
    Sci Rep; 2018 Jul; 8(1):10635. PubMed ID: 30006587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes.
    Oresic M; Gopalacharyulu P; Mykkänen J; Lietzen N; Mäkinen M; Nygren H; Simell S; Simell V; Hyöty H; Veijola R; Ilonen J; Sysi-Aho M; Knip M; Hyötyläinen T; Simell O
    Diabetes; 2013 Sep; 62(9):3268-74. PubMed ID: 23630305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal plasma lipidomics dataset from children who developed islet autoimmunity and type 1 diabetes.
    Lamichhane S; Ahonen L; Dyrlund TS; Siljander H; Hyöty H; Ilonen J; Toppari J; Veijola R; Hyötyläinen T; Knip M; Orešič M
    Sci Data; 2018 Nov; 5():180250. PubMed ID: 30422126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of secondary bile acid metabolism precedes islet autoimmunity and type 1 diabetes.
    Lamichhane S; Sen P; Dickens AM; Alves MA; Härkönen T; Honkanen J; Vatanen T; Xavier RJ; Hyötyläinen T; Knip M; Orešič M
    Cell Rep Med; 2022 Oct; 3(10):100762. PubMed ID: 36195095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic alterations in immune cells associate with progression to type 1 diabetes.
    Sen P; Dickens AM; López-Bascón MA; Lindeman T; Kemppainen E; Lamichhane S; Rönkkö T; Ilonen J; Toppari J; Veijola R; Hyöty H; Hyötyläinen T; Knip M; Orešič M
    Diabetologia; 2020 May; 63(5):1017-1031. PubMed ID: 32043185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in pancreatic exocrine function in young at-risk children followed to islet autoimmunity and type 1 diabetes in the ENDIA study.
    Penno MAS; Oakey H; Augustine P; Taranto M; Barry SC; Colman PG; Craig ME; Davis EA; Giles LC; Harris M; Haynes A; McGorm K; Morahan G; Morbey C; Rawlinson WD; Sinnott RO; Soldatos G; Thomson RL; Vuillermin PJ; Wentworth JM; Harrison LC; Couper JJ
    Pediatr Diabetes; 2020 Sep; 21(6):945-949. PubMed ID: 32430977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Have Slow Progressors Taught Us About T1D-Mind the Gap!
    Gillespie KM; Long AE
    Curr Diab Rep; 2019 Sep; 19(10):99. PubMed ID: 31501992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating metabolites in progression to islet autoimmunity and type 1 diabetes.
    Lamichhane S; Kemppainen E; Trošt K; Siljander H; Hyöty H; Ilonen J; Toppari J; Veijola R; Hyötyläinen T; Knip M; Orešič M
    Diabetologia; 2019 Dec; 62(12):2287-2297. PubMed ID: 31444528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early childhood CMV infection may decelerate the progression to clinical type 1 diabetes.
    Ekman I; Vuorinen T; Knip M; Veijola R; Toppari J; Hyöty H; Kinnunen T; Ilonen J; Lempainen J
    Pediatr Diabetes; 2019 Feb; 20(1):73-77. PubMed ID: 30338642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age.
    Lindberg B; Ivarsson SA; Landin-Olsson M; Sundkvist G; Svanberg L; Lernmark A
    Diabetologia; 1999 Feb; 42(2):181-7. PubMed ID: 10064098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort.
    Andersson Svärd A; Kaur S; Trôst K; Suvitaival T; Lernmark Å; Maziarz M; Pociot F; Overgaard AJ;
    Metabolomics; 2020 Oct; 16(10):109. PubMed ID: 33033923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of growth patterns and islet autoimmunity in children with increased risk for type 1 diabetes: a functional analysis approach.
    Yassouridis C; Leisch F; Winkler C; Ziegler AG; Beyerlein A
    Pediatr Diabetes; 2017 Mar; 18(2):103-110. PubMed ID: 26890567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion.
    Bonifacio E; Krumsiek J; Winkler C; Theis FJ; Ziegler AG
    Acta Diabetol; 2014; 51(3):403-11. PubMed ID: 24249616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
    Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
    Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased cord-blood phospholipids in young age-at-onset type 1 diabetes.
    La Torre D; Seppänen-Laakso T; Larsson HE; Hyötyläinen T; Ivarsson SA; Lernmark A; Oresic M;
    Diabetes; 2013 Nov; 62(11):3951-6. PubMed ID: 23929934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to environmental factors in drinking water: risk of islet autoimmunity and type 1 diabetes--the BABYDIAB study.
    Winkler C; Mollenhauer U; Hummel S; Bonifacio E; Ziegler AG
    Horm Metab Res; 2008 Aug; 40(8):566-71. PubMed ID: 18500677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.
    Snowhite IV; Allende G; Sosenko J; Pastori RL; Messinger Cayetano S; Pugliese A
    Diabetologia; 2017 Aug; 60(8):1409-1422. PubMed ID: 28500393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory infections in early life and the development of islet autoimmunity in children at increased type 1 diabetes risk: evidence from the BABYDIET study.
    Beyerlein A; Wehweck F; Ziegler AG; Pflueger M
    JAMA Pediatr; 2013 Sep; 167(9):800-7. PubMed ID: 23818010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 25-Hydroxyvitamin D Concentrations in Children Progressing to Autoimmunity and Clinical Type 1 Diabetes.
    Mäkinen M; Mykkänen J; Koskinen M; Simell V; Veijola R; Hyöty H; Ilonen J; Knip M; Simell O; Toppari J
    J Clin Endocrinol Metab; 2016 Feb; 101(2):723-9. PubMed ID: 26695863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.